New single shot COVID19 vaccine

7 March 2021 by IdeaSpies

COVID-19

The new Johnson & Johnson single-shot COVID-19 vaccine shows protection across countries with different variants. A vaccine that protects against COVID-19, especially against the most dire outcomes of hospitalisation and death, will help ease the burden on people and the strain on health systems worldwide.

The vaccine, similar to the AstraZeneca option, is a viral vector vaccine which use an adenovirus to deliver DNA into our cells,

DNA is not as fragile as the mRNA in the Pfizer vaccine, which is why both viral vector jabs can be stored in a fridge (and the Pfizer must be kept below minus-70 degrees Celsius),

https://www.npr.org/sections/coronavirus-live-updates/2021/03/01/972538146/johnson-johnson-vaccine-rollout-begins-in-u-s-as-covid-19-cases-tick-up

What do you think?

You must be logged in to post a comment.

Comments

COVID-19

siRNA for Treatment of SARS-CoV-2

RNA interference in animals involves small double-stranded RNA molecules called siRNA. These molecules are valuable tools for studying single gene function in both in vivo and in vitro settings and are also considered a promising class of therapeutics. SiRNA delivery systems fall into two categories: viral and non-viral, including peptides, polymers, and lipids. Studies using synthetic or plasmid-encoded siRNA show its antiviral effects against various viruses, including SARS-CoV. Learn more about siRNA for Treatment of SARS-CoV-2: https://sars-cov-2.creative-biolabs.com/sirna-for-the-treatment-of-sars-cov2.htm

27 September 2023 by Creative Biol... 0 Comments

COVID-19

Vaccine factories in shipping containers

BioNTech, which co-developed a revolutionary mRNA covid-19 vaccine in partnership with Pfizer, hopes to revolutionise another area of pharmaceuticals: vaccine manufacturing. It is developing vaccine factories to sit inside a series of standard metal shipping containers, which it plans to send to parts of the world that lack their own vaccine-manufacturing capabilities-notably Africa. Each facility, BioNTech says, will be able to produce up to 60m doses of covid vaccines and other vaccines each year, and will cost "significantly less" than conventional factories. If so, this could be the future of drugmaking. https://www.economist.com/science-and-technology/biontech-plans-to-make-vaccines-in-shipping-containers/

18 February 2022 by IdeaSpies 0 Comments